In June 2018, the FDA approved GW Pharmaceutical's Epidiolex, a CBD-based drug for treating epileptic seizures - marking the first time the agency has ever approved a drug derived from marijuana.
IDVV
(0)
(0)
International Endeavors Corp (IDVV) Stock Research Links
